نتائج البحث

Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia.

• Authors : Garrett M; Pfizer Oncology, San Diego, California, USA.; Knight B

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/drug therapy

• Source: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17981-17992. Date of Electronic Publication: 2023 Aug 08.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.

• Authors : Li JB; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou, Guangzhou, P. R. China.; Ke KJ

Subjects: Colonoscopy* ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/diagnosis ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/epidemiology

• Source: Cancer medicine [Cancer Med] 2022 Nov; Vol. 11 (22), pp. 4321-4331. Date of Electronic Publication: 2022 Apr 20.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

• Authors : Deleporte A; Department of Medicine, Gastrointestinal Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.; Van den Eynde M

Subjects: Esophagogastric Junction*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects

• Source: Cancer medicine [Cancer Med] 2021 Jul; Vol. 10 (13), pp. 4366-4374. Date of Electronic Publication: 2021 May 31.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel.

• Authors : Hoogland AI; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.; Jayani RV

Subjects: Patient Reported Outcome Measures* ; Quality of Life*; Antigens, CD19/Antigens, CD19/Antigens, CD19/*therapeutic use

• Source: Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 1936-1943. Date of Electronic Publication: 2021 Feb 28.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Effects of lapatinib or trastuzumab, alone and in combination, in human epidermal growth factor receptor 2-positive breast cancer: a meta-analysis of randomized controlled trials.

• Authors : Xin, Yong; Guo, Wen Wen; Huang, Qian

Subjects: HORMONE receptor positive breast cancer; EPIDERMAL growth factor receptors; LAPATINIB

• Source: Cancer Medicine; Dec2016, Vol. 5 Issue 12, p3454-3463, 10p

تفاصيل العنوان

A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.

• Authors : Zhou Y; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Zhang X

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Dasatinib/Dasatinib/Dasatinib/*administration & dosage ; Dasatinib/Dasatinib/Dasatinib/*therapeutic use

• Source: Cancer medicine [Cancer Med] 2020 Sep; Vol. 9 (17), pp. 6225-6233. Date of Electronic Publication: 2020 Jul 17.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms

• Authors : Ji‐Bin Li; Keng‐Jian Ke; Wei‐Li Zhang

Subjects: Diarrhea; Cancer Research; Oncology

• Source: Cancer medicine. 11(22)

تفاصيل العنوان

Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments.

• Authors : Thomas, Caitlin¹ (AUTHOR) ; Marsh, Kevin¹ (AUTHOR); Trapali, Myrto¹ (AUTHOR)

• Source: Cancer Medicine. Oct2024, Vol. 13 Issue 19, p1-12. 12p.

تفاصيل العنوان

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer.

• Authors : Long, Jieran¹ (AUTHOR); Li, Xuefei² (AUTHOR); Wu, Lin³ (AUTHOR)

• Source: Cancer Medicine. Sep2024, Vol. 13 Issue 17, p1-14. 14p.

تفاصيل العنوان

Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study

• Authors : Marc De Man; Pascal Pierre; Erik Vanderstraeten ...

Subjects: Male; 0301 basic medicine; Cancer Research

• Source: Cancer medicine, Vol. 10, no. 13, p. 4366-4374 (2021)Cancer Medicine, Vol 10, Iss 13, Pp 4366-4374 (2021)

تفاصيل العنوان